Parallax Volatility Advisers, L.P. Insmed Inc Transaction History
Parallax Volatility Advisers, L.P.
- $35.7 Billion
- Q1 2025
A detailed history of Parallax Volatility Advisers, L.P. transactions in Insmed Inc stock. As of the latest transaction made, Parallax Volatility Advisers, L.P. holds 200 shares of INSM stock, worth $20,318. This represents 0.0% of its overall portfolio holdings.
Number of Shares
200
Previous 70,537
99.72%
Holding current value
$20,318
Previous $4.87 Million
99.69%
% of portfolio
0.0%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding INSM
# of Institutions
489Shares Held
197MCall Options Held
892KPut Options Held
1.77M-
Vanguard Group Inc Valley Forge, PA18.3MShares$1.86 Billion0.03% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y915.4MShares$1.56 Billion81.63% of portfolio
-
Black Rock Inc. New York, NY14.3MShares$1.45 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.9MShares$1.31 Billion0.12% of portfolio
-
Capital International Investors Los Angeles, CA7.2MShares$731 Million0.11% of portfolio
About INSMED Inc
- Ticker INSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,476,992
- Market Cap $13.8B
- Description
- Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...